Browse > Article

Clinical Presentation and Management of Five Dogs with Apocrine Gland Adenocarcinoma of Anal Sac  

Oh, Ye-In (College of Veterinary Medicine, Seoul National University)
Seo, Kyoung-Won (College of Veterinary Medicine, Seoul National University)
Kim, Jun-Young (College of Veterinary Medicine, Seoul National University)
Youn, Jung-Hee (College of Veterinary Medicine, Seoul National University)
Hwang, Cheol-Young (College of Veterinary Medicine, Seoul National University)
Lee, Sang-Koo (Center for Laboratory Animal Science, College of Medicine, Hanyang University)
Youn, Hwa-Young (College of Veterinary Medicine, Seoul National University)
Publication Information
Journal of Veterinary Clinics / v.26, no.6, 2009 , pp. 606-611 More about this Journal
Abstract
Five dogs diagnosed as apocrine gland adenocarcinoma (AGAC) of the anal sac based on cytology and/or histology. Mean age of these dogs was 11 years old. One dog treated with supportive care without other medical interventions for hypercalcemia was died one month after diagnosis. Other four dogs were treated with chemotherapy and one of these dogs was intervened with complete surgical resection. Two months after the diagnosis, one of the dogs treated with chemotherapy died. The survival time of other survived three dogs from the time of diagnosis was 19, 9, and 13 months respectively and they are still alive at this time. After chemotherapy, three dogs were managed generally in good body condition and maintained as similar in size as time of diagnosis. The results are suggested that it is worthwhile to try chemotherapy for managing AGAC in dogs especially complicated or metastasized to regional lymph nodes.
Keywords
Anal sac; apocrine gland adenocarcinoma; chemotherapy; dog;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Rosol TJ, Capen CC, Danks JA et al. Identification of parathyroid hormone-related protein in canine apocrine adenocarcinoma of the anal sac. Vet Pathol 1990; 27: 89-95   DOI   ScienceOn
2 Williams LE, Gliatto JM, Dodge RK et al. Carcinoma of the apocrine glands of the anal sac in dogs: 113 dogs (1985-1995). J Am Vet Med Assoc 2003; 223: 825-831   DOI   ScienceOn
3 Bidur P, Min Soo K, Il Hong B, Mi Sun P et al. Retrospective study of canine cutaneous tumors in Korea. J Vet Sci 2007; 8: 229-236   DOI   ScienceOn
4 S G Emms. Anal sac tumours of the dog and their response to cytoreductive surgery and chemotherapy. Aust Vet J 2005; 83: 340-343   DOI   ScienceOn
5 Elemir S, Brian PW, Julie AY. A retrospective study of 44 canine apocrine sweat gland adenocarcinomas. Can Vet J 2003; 44: 38-42
6 Morabito A, Bevilacqua P, Vitale S, Fanelli M, Gattuso D, Gasparini G. Clinical management of a case of recurrent apocrine gland carcinoma of the scalp: efficacy of a chemotherapy schedule with methotrexate and bleomycin. Tumori 2000; 86: 472-474
7 Grone A, Werkmeister JR, Steinmeyer CL et al. Parathyroid hormone-related protein in normal and neoplastic canine tissues: Immunohistochemical localization and biochemical extraction. Vet Pathol 1994; 31: 308-315   DOI   ScienceOn
8 Spugnini EP, Dotsinsky I, Mudrov N, Bufalini M, Giannini G, Citro G, Feroce F, Baldi A. Adjuvant electrochemotherapy for incompletely excised anal sac carcinoma in a dog. In Vivo 2008; 22: 47-49
9 Howard PH, Marjorie RB, Kenita SR. Surgery of metastatic anal sac adenocarcinoma in five dogs. Vet Surg 2006; 35: 267-270.17   DOI   ScienceOn
10 Ross JT, Scavelli TD, Matthiesen DT et al. Adenocarcinoma of the apocrine glands of the anal sac in dogs: a review of 32 cases. J Am Anim Hosp Assoc 1991; 27: 349-355
11 Tozon N, Kodre V, Sersa G, Cemazar M. Effective treatment of perianal tumors in dogs with electrochemotherapy. Anticancer Res 2005; 25: 839-845
12 Meuten DJ, Cooper BJ, Capen CC et al. Hypercalcemia associated with an adenocarcinoma derived from the apocrine glands of the anal sac. Vet Pathol 1981; 18: 454-471
13 Zeppetella G, Ribeiro MD. Opioids for the management of breakthrough (episodic) pain in cancer patients. Cochrane Database Syst Rev 2006; 25: CD004311
14 Bennett PF, DeNicola DB, Bonney P, Glickman NW, Knapp DW. Canine anal sac adenocarcinomas: clinical presentation and response to therapy. J Vet Intern Med 2002; 16(1): 100-104   DOI   ScienceOn
15 W Bertazzolo, S Comazzi, P Roccabianca, M Caniatti. Hypercalcaemia associated with a retroperitoneal apocrine gland adenocarcinoma in a dog. J Small Anim Pract. 2003; 44: 221-224   DOI   ScienceOn
16 Berrocal A, Vos JH, Ingh TSGAM van den, Molenbeek. RF, Sluijs FJ van. Canine perineal tumors. J Vet Med Ser A 1989; 36: 739-749   DOI
17 Portenoy RK, Payne R, Coluzzi P, Raschko JW, Lyss A, Busch MA, Frigerio V, Ingham J, Loseth DB, Nordbrock E, Rhiner M. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study. Pain 1999; 79: 303-312   DOI
18 Goldschmidt MH, Zoltowski C. Anal sac gland adenocarcinoma in the dog: 14 cases. J Small Anim Pract 1981; 22: 119-128   DOI   ScienceOn
19 Peter FB, Denis BD, Patty B, Nita WG, Deborah WK. Canine anal sac adenocarcinomas: clinical presentation and response to therapy. J Vet Intern Med. 2002; 16: 100-104   DOI   ScienceOn